Gilead says arthritis drug filgotinib fails in follow-up use...

Could phase 3 trial win save AZ's troubled Lupus drug?

AstraZeneca has been on a hot streak of trial successes recently, with the latest win being in a late-stage study for a potential lupus drug that looked dead and buried after a major trial

Roche's Gazyva shows promise in Lupus nephritis trial

Roche’s Gazyva is already approved in leukaemia and lymphoma – but could it work in the autoimmune kidney disease Lupus nephritis too?

FDA approves first treatment for children with lupus

The US FDA has approved GSK’s Benlysta (belimumab) intravenous infusion for the treatment of children with lupus.

AZ's lupus drug fails in late-stage trial

AZ will launch full review after further phase 3 results later this year

Gilead to collaborate with Google’s Verily in inflammatory d...

Gilead has signed a three-year deal with Google’s life science division Verily to work on identifying the immunological and molecular drivers behind three inflammatory diseases.